TARGETTI, MATTIA
 Distribuzione geografica
Continente #
EU - Europa 958
NA - Nord America 941
AS - Asia 254
AF - Africa 5
SA - Sud America 1
Totale 2.159
Nazione #
US - Stati Uniti d'America 939
RU - Federazione Russa 365
PL - Polonia 184
IT - Italia 159
IE - Irlanda 95
SE - Svezia 90
SG - Singapore 79
HK - Hong Kong 55
CN - Cina 49
IN - India 30
JO - Giordania 25
DE - Germania 13
VN - Vietnam 10
GB - Regno Unito 9
CH - Svizzera 7
DK - Danimarca 7
FI - Finlandia 6
UA - Ucraina 5
ES - Italia 4
FR - Francia 4
RO - Romania 4
BE - Belgio 3
KR - Corea 3
CA - Canada 2
CI - Costa d'Avorio 2
MA - Marocco 2
NL - Olanda 2
BR - Brasile 1
GE - Georgia 1
PT - Portogallo 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 2.159
Città #
Santa Clara 212
Warsaw 181
Dublin 95
Fairfield 86
Chandler 63
Singapore 62
Ashburn 51
Seattle 46
Ann Arbor 39
Hong Kong 35
Woodbridge 34
Houston 33
Wilmington 33
Cambridge 30
Lawrence 29
Altamura 28
Florence 28
Mumbai 28
Princeton 18
Scandicci 17
Shanghai 17
Beijing 16
Boston 16
Buffalo 12
New York 12
Munich 11
Boardman 9
Bern 7
Copenhagen 7
Siena 7
Andover 6
Fontebuona 6
Medford 6
Moscow 6
Milan 5
Barcelona 4
Changsha 4
Dearborn 4
Dong Ket 4
Helsinki 4
London 4
Salerno 4
San Diego 4
Yubileyny 4
Bologna 3
Brussels 3
Castelfiorentino 3
Ho Chi Minh City 3
Livorno 3
Los Angeles 3
Rome 3
Timisoara 3
Washington 3
Abidjan 2
Campi Bisenzio 2
Colle di Val d'Elsa 2
Easley 2
Kent 2
Norwalk 2
Prato 2
Pune 2
Romola 2
Salé 2
Seoul 2
St. Catharines 2
Thiene 2
Vicenza 2
West Jordan 2
Americana 1
Amsterdam 1
Barletta 1
Bruino 1
Chiswick 1
Council Bluffs 1
Dongyang 1
Duncan 1
Falls Church 1
Frankfurt am Main 1
Genova 1
Guangzhou 1
Hanoi 1
Heze 1
Hillsboro 1
Islington 1
Jacksonville 1
Mem Martins 1
Naples 1
Phoenix 1
Redmond 1
San Miniato Basso 1
Sesto Fiorentino 1
Sestri Levante 1
Shaoxing 1
Southwark 1
Staranzano 1
Totale 1.411
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 326
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 140
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 132
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 132
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 122
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 107
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 103
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 102
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 85
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 80
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 71
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 69
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 69
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 69
Cellular Retrograde Cardiomyoplasty and Relaxin Therapyfor Postischemic Myocardial Repair in a Rat Model 68
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 67
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 56
[From loss to prevention: lessons to be learned from juvenile sudden death] 53
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 53
Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration 51
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 49
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 48
Diagnostic Delay in Arrhythmogenic Cardiomyopathy 43
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 42
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 37
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs 19
Totale 2.193
Categoria #
all - tutte 7.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020227 0 0 0 0 29 27 40 39 33 20 29 10
2020/2021209 17 24 9 28 8 14 6 16 18 46 13 10
2021/2022134 4 9 7 8 4 6 8 10 6 11 23 38
2022/2023444 30 105 26 9 23 61 61 29 50 8 31 11
2023/2024245 5 20 31 16 25 44 18 43 8 7 12 16
2024/2025800 56 142 111 205 286 0 0 0 0 0 0 0
Totale 2.193